Profil
Tirtha Chakraborty currently works at Specific Biologics, Inc., as Advisor from 2023.
Dr. Chakraborty also formerly worked at CRISPR Therapeutics AG, as Executive Director & Head-Hematology from 2015 to 2018, Sana Biotechnology, Inc., as Vice President-Cell Therapy Research from 2018 to 2019, and Vor Biopharma, Inc., as Chief Scientific Officer from 2020 to 2025.
Dr. Chakraborty received his doctorate degree from Tata Institute of Fundamental Research.
Postes actifs de Tirtha Chakraborty
| Sociétés | Poste | Début |
|---|---|---|
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel gene editing technologies to treat diseases at the genetic level in cells inside the body | Consultant / Advisor | 24/07/2023 |
Anciens postes connus de Tirtha Chakraborty
| Sociétés | Poste | Fin |
|---|---|---|
| VOR BIOPHARMA INC. | Directeur Technique/Scientifique/R&D | 16/05/2025 |
| SANA BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 01/10/2019 |
| CRISPR THERAPEUTICS AG | Directeur/Membre du Conseil | 01/10/2018 |
Formation de Tirtha Chakraborty
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Tata Institute of Fundamental Research
Tata Institute of Fundamental Research Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Vor Biopharma, Inc.
Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
Sana Biotechnology, Inc.
Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
Specific Biologics, Inc.
Specific Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel gene editing technologies to treat diseases at the genetic level in cells inside the body | Commercial Services |
















